Skip to main content
Pfizer COVID-19 vaccine appointments are available to our patients.
Sign up for Connect today
to schedule your vaccination.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Jill Roberts Center for Inflammatory Bowel Disease
Explore this Website
Home
About Us
Toggle About Us menu options
Clinical Staff
Research Staff
Contact Us
Newsworthy
Toggle Newsworthy menu options
News and Announcements
Patient Care
Toggle Patient Care menu options
Clinical Services
FAQs
For Your Visit
COVID-19 Information
Nutrition Science
Toggle Nutrition Science menu options
Nutrition FAQs
Food Intolerances
News in IBD Nutrition
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Clinical Trials
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Newsworthy
Patient Care
Nutrition Science
Research and Clinical Trials
Home
Publications
Publications
Clinical Trials
Publications
Found 43 results
Author
Title
Type
[
Year
]
Filters:
First Letter Of Last Name
is
R
[Clear All Filters]
2021
Hassan-Zahraee M
,
Ye Z
,
Xi L
,
Baniecki MLynn
,
Li X
,
Hyde CL
,
Zhang J
,
Raha N
,
Karlsson F
,
Quan J
et al.
. 2021.
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
.
Inflamm Bowel Dis.
Hassan-Zahraee M
,
Ye Z
,
Xi L
,
Baniecki MLynn
,
Li X
,
Hyde CL
,
Zhang J
,
Raha N
,
Karlsson F
,
Quan J
et al.
. 2021.
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.
.
Inflamm Bowel Dis.
Yarur AJ
,
Deepak P
,
Casteele NVande
,
Battat R
,
Jain A
,
Okada L
,
Osterman M
,
Regueiro M
. 2021.
Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases.
.
Dig Dis Sci. 66(10):3563-3569.
Shen B
,
Kochhar GS
,
Kariv R
,
Liu X
,
Navaneethan U
,
Rubin DT
,
Cross RK
,
Sugita A
,
D'Hoore A
,
Schairer J
et al.
. 2021.
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.
.
Lancet Gastroenterol Hepatol. 6(10):826-849.
Shen B
,
Kochhar GS
,
Kariv R
,
Liu X
,
Navaneethan U
,
Rubin DT
,
Cross RK
,
Sugita A
,
D'Hoore A
,
Schairer J
et al.
. 2021.
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium.
.
Lancet Gastroenterol Hepatol. 6(10):826-849.
Kayal M
,
Ungaro RC
,
Riggs A
,
Kamal K
,
Agrawal M
,
Cohen-Mekelburg S
,
Axelrad J
,
Faye A
,
Scherl E
,
Lawlor G
et al.
. 2021.
Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability.
.
Clin Gastroenterol Hepatol.
Ma C
,
Sedano R
,
Almradi A
,
Casteele NVande
,
Parker CE
,
Guizzetti L
,
Schaeffer DF
,
Riddell RH
,
Pai RK
,
Battat R
et al.
. 2021.
An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.
.
Gastroenterology. 160(7):2291-2302.
Ma C
,
Sedano R
,
Almradi A
,
Casteele NVande
,
Parker CE
,
Guizzetti L
,
Schaeffer DF
,
Riddell RH
,
Pai RK
,
Battat R
et al.
. 2021.
An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.
.
Gastroenterology. 160(7):2291-2302.
Ma C
,
Sedano R
,
Almradi A
,
Casteele NVande
,
Parker CE
,
Guizzetti L
,
Schaeffer DF
,
Riddell RH
,
Pai RK
,
Battat R
et al.
. 2021.
An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.
.
Gastroenterology. 160(7):2291-2302.
Gu W
,
Wang H
,
Huang X
,
Kraiczy J
,
Singh PNP
,
Ng C
,
Dagdeviren S
,
Houghton S
,
Pellon-Cardenas O
,
Lan Y
et al.
. 2021.
SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling.
.
Cell Stem Cell.
Gu W
,
Wang H
,
Huang X
,
Kraiczy J
,
Singh PNP
,
Ng C
,
Dagdeviren S
,
Houghton S
,
Pellon-Cardenas O
,
Lan Y
et al.
. 2021.
SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling.
.
Cell Stem Cell.
Zegarra-Ruiz DF
,
Kim DV
,
Norwood K
,
Kim M
,
Wu W-JH
,
Saldana-Morales FB
,
Hill AA
,
Majumdar S
,
Orozco S
,
Bell R
et al.
. 2021.
Thymic development of gut-microbiota-specific T cells.
.
Nature. 594(7863):413-417.
2020
Dulai PS
,
Singh S
,
Casteele NVande
,
Meserve J
,
Winters A
,
Chablaney S
,
Aniwan S
,
Shashi P
,
Kochhar G
,
Weiss A
et al.
. 2020.
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
.
Clin Gastroenterol Hepatol. 18(13):2952-2961.e8.
Panaccione R
,
Danese S
,
Sandborn WJ
,
O'Brien CD
,
Zhou Y
,
Zhang H
,
Adedokun OJ
,
Tikhonov I
,
Targan S
,
Abreu MT
et al.
. 2020.
Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy.
.
Aliment Pharmacol Ther. 52(11-12):1658-1675.
2019
Battat R
,
Dulai PS
,
Casteele NVande
,
Evans E
,
Hester KD
,
Webster E
,
Jain A
,
Proudfoot JA
,
Mairalles A
,
Neill J
et al.
. 2019.
Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis.
.
Inflamm Bowel Dis. 25(2):410-420.
Lukin DJ
,
Lawlor G
,
Hudesman DP
,
Durbin L
,
Axelrad JE
,
Passi M
,
Cavaliere K
,
Coburn E
,
Loftus M
,
Jen H
et al.
. 2019.
Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
.
Inflamm Bowel Dis. 25(4):775-781.
Gogokhia L
,
Buhrke K
,
Bell R
,
Hoffman B
,
D Brown G
,
Hanke-Gogokhia C
,
Ajami NJ
,
Wong MC
,
Ghazaryan A
,
Valentine JF
et al.
. 2019.
Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.
.
Cell Host Microbe. 25(2):285-299.e8.
Cohen-Mekelburg S
,
Rosenblatt R
,
Gold S
,
Shen N
,
Fortune B
,
Waljee AK
,
Saini S
,
Scherl E
,
Burakoff R
,
Unruh M
. 2019.
Fragmented Care is Prevalent Among Inflammatory Bowel Disease Readmissions and is Associated With Worse Outcomes.
.
Am J Gastroenterol. 114(2):276-290.
Cohen-Mekelburg S
,
Schneider Y
,
Gold S
,
Ghosh G
,
Rosenblatt R
,
Hajifathalian K
,
Scherl E
,
Schnoll-Sussman F
,
Katz P
,
Steinlauf A
. 2019.
Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care.
.
Dig Dis Sci. 64(8):2273-2279.
Qazi T
,
Verma R
,
Hamilton MJ
,
Kaplan ER
,
Redline S
,
Burakoff R
. 2019.
The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease.
.
Inflamm Bowel Dis. 25(6):1044-1053.
2018
Dulai PS
,
Boland BS
,
Singh S
,
Chaudrey K
,
Koliani-Pace JL
,
Kochhar G
,
Parikh MP
,
Shmidt E
,
Hartke J
,
Chilukuri P
et al.
. 2018.
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
.
Gastroenterology. 155(3):687-695.e10.
Cohen-Mekelburg S
,
Rosenblatt R
,
Gold S
,
Burakoff R
,
Waljee AK
,
Saini S
,
Schackman BR
,
Scherl E
,
Crawford C
. 2018.
The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients.
.
J Crohns Colitis. 12(9):1030-1035.
Battat R
,
Duijvestein M
,
Casteele NVande
,
Singh S
,
Dulai PS
,
Valasek MA
,
Mimms L
,
McFarland J
,
Hester KD
,
Renshaw M
et al.
. 2018.
Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
.
Clin Gastroenterol Hepatol.
2017
Battat R
,
Kopylov U
,
Byer J
,
Sewitch MJ
,
Rahme E
,
Nedjar H
,
Zelikovic E
,
Dionne S
,
Bessissow T
,
Afif W
et al.
. 2017.
Vitamin B12 deficiency in inflammatory bowel disease: a prospective observational pilot study.
.
Eur J Gastroenterol Hepatol. 29(12):1361-1367.
2015
Huang C
,
Haritunians T
,
Okou DT
,
Cutler DJ
,
Zwick ME
,
Taylor KD
,
Datta LW
,
Maranville JC
,
Liu Z
,
Ellis S
et al.
. 2015.
Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.
.
Gastroenterology. 149(6):1575-86.
1
(current)
2
next ›
last »